hVIVO making four poster presentations at ISIRV AVG 2018, Washington, D.C. USA, Nov 2018
October 29, 2018 11:22 am6th Advances in Respiratory Virus Therapeutics, 13 November – 15 November 2018
hVIVO will be making four scientific poster presentations at the ISIRV AVG 2018 conference in Washington, DC USA, 2018.
- Topic: “Human viral challenge model: A systematic analysis of placebo population data from six RSV studies.”
Nicolas Noulin, Associate Director, Scientific Operations, hVIVO - Topic: “Use of qualitative integrated Cycler PCR to trigger therapeutic/placebo dosing in human experimental infection: a retrospective analysis.”
Nicolas Noulin, Associate Director, Scientific Operations, hVIVO - Topic: “The utilisation of enhanced assay strategies for the RSV human challenge model.”
Brandon Löndt, Development Operations Manager - Topic: “The RSV Human Viral Challenge Model: Over a decade of experience, what next?”
Rob Lambkin-Williams, Executive Scientific Advisor, hVIVO
hVIVO’s Scientific and Operations Director, and Senior Director Business Development, will both be available for meetings at the congress.
If you would like to schedule a meeting with hVIVO at ISIRV AVG 2018, contact us.
Comments are closed here.